Rakha EA, Miligy IM, Quinn CM, Provenzano E, et al. Retrospective observational study of HER2 immunohistochemistry in borderline breast cancer patients undergoing neoadjuvant therapy, with an emphasis on Group 2 (HER2/CEP17 ratio >/=2.0, HER2 copy number <4.0 signals/cell) cases. Br J Cancer 2021 Mar 24. pii: 10.1038/s41416-021-01351.
PMID: 33762723